Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 1996-10-25 M&A Activity
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Ad hoc-Service: Fresenius AG
M&A Activity Classification · 99% confidence The document is a short, ad-hoc announcement dated October 25, 1996, detailing the acquisition of a majority stake in Laevosan-Gesellschaft mbH by Fresenius AG. This describes a significant corporate transaction involving a merger or takeover proposal (acquisition of a majority stake). According to the definitions, this falls under M&A Activity (TAR). It is not a full report, a dividend notice, or a management change, but a specific transaction announcement.
1996-10-25 German
Ad hoc-Service: Fresenius AG
Earnings Release Classification · 99% confidence The document text is very short (879 characters) and presents key financial highlights (Umsatz/Revenue and Ergebnis/Earnings) for the 'first half of 1996' (erstes Halbjahr 1996). This structure—providing summarized, period-specific financial results immediately upon release—is characteristic of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR) nor is it merely an announcement that a report is forthcoming (RPA). The content focuses purely on the results themselves. H1 1996
1996-08-09 German
Ad hoc-Service: Fresenius AG
M&A Activity Classification · 98% confidence The document is a short 'Ad-hoc-Service' announcement dated July 26, 1996, from Fresenius AG. It reports the sale of a subsidiary (Schiwa GmbH) to B.Braun Melsungen AG. This transaction is explicitly stated as a prerequisite for a larger planned merger of Fresenius's global dialysis business with National Medical Care. This type of announcement detailing a significant corporate transaction, specifically a merger/acquisition component, falls under the scope of M&A Activity (TAR). Since the document is short and reports the event directly, it is classified as TAR rather than a general regulatory filing (RNS).
1996-07-26 German

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.